Revance Therapeutics Statistics

Total Valuation

NSE:KAYNES has a market cap or net worth of INR 389.84 billion. The enterprise value is 388.44 billion.

Market Cap	389.84B
Enterprise Value	388.44B

Important Dates

The last earnings date was Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:KAYNES has 67.03 million shares outstanding. The number of shares has increased by 12.29% in one year.

Current Share Class	67.03M
Shares Outstanding	67.03M
Shares Change (YoY)	+12.29%
Shares Change (QoQ)	+37.68%
Owned by Insiders (%)	55.06%
Owned by Institutions (%)	24.30%
Float	30.13M

Valuation Ratios

The trailing PE ratio is 128.09 and the forward PE ratio is 74.46. NSE:KAYNES's PEG ratio is 1.81.

PE Ratio	128.09
Forward PE	74.46
PS Ratio	13.48
PB Ratio	13.71
P/TBV Ratio	14.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.81

Financial Ratio History

Enterprise Valuation

EV / Earnings	122.43
EV / Sales	13.44
EV / EBITDA	85.63
EV / EBIT	95.69
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.32
Debt / EBITDA	1.99
Debt / FCF	n/a
Interest Coverage	3.81

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	7.74%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	18.45M
Profits Per Employee	2.02M
Employee Count	1,567
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:KAYNES has paid 863.27 million in taxes.

Income Tax	863.27M
Effective Tax Rate	21.39%

Stock Price Statistics

The stock price has increased by +35.93% in the last 52 weeks. The beta is -0.41, so NSE:KAYNES's price volatility has been lower than the market average.

Beta (5Y)	-0.41
52-Week Price Change	+35.93%
50-Day Moving Average	5,873.82
200-Day Moving Average	5,647.27
Relative Strength Index (RSI)	45.96
Average Volume (20 Days)	633,299

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:KAYNES had revenue of INR 28.91 billion and earned 3.17 billion in profits. Earnings per share was 45.40.

Revenue	28.91B
Gross Profit	9.52B
Operating Income	4.06B
Pretax Income	4.04B
Net Income	3.17B
EBITDA	4.47B
EBIT	4.06B
Earnings Per Share (EPS)	45.40

Full Income Statement

Balance Sheet

The company has 10.47 billion in cash and 9.03 billion in debt, giving a net cash position of 1.44 billion or 21.44 per share.

Cash & Cash Equivalents	10.47B
Total Debt	9.03B
Net Cash	1.44B
Net Cash Per Share	21.44
Equity (Book Value)	28.44B
Book Value Per Share	443.21
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 32.91%, with operating and profit margins of 14.04% and 10.97%.

Gross Margin	32.91%
Operating Margin	14.04%
Pretax Margin	13.96%
Profit Margin	10.97%
EBITDA Margin	15.46%
EBIT Margin	14.04%
FCF Margin	n/a

Dividends & Yields

NSE:KAYNES does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.29%
Shareholder Yield	n/a
Earnings Yield	0.81%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2